CLINICAL_TRIALS
withdrawal
· 2014-04-29
Clinical Trial Update: A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide [Phase 2]
Summary
A Phase 2 randomized, open-label trial evaluating addition of acetazolamide to the standard triple regimen for Helicobacter pylori infection, which has been wit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yonsei University | Conditions: H. Pylori Infection | Phase 2 | Status: WITHDRAWN